NEXGEL, Inc. (NXGLW) 股票分析

公司概述

NEXGEL, Inc. (NXGLW) operates within the healthcare and consumer goods sectors, specifically manufacturing and selling high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for applications including wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. The company conducts its operations through two distinct segments: Nexgel and CG labs, which collectively serve diverse markets ranging from medical to cosmetic industries. The firm currently lists under the ticker NXGLW and maintains a price-to-book ratio of 0.06, reflecting a specific valuation multiple relative to its shareholders' equity. In terms of scale, the company reported an annual revenue of $11.42 million over the trailing twelve months, while specific data regarding its market capitalization, P/E ratio, and employee count is not available in the current reporting period. These financial figures indicate that the business functions with a modest revenue base, positioning it as a specialized niche player rather than a large-cap diversified entity, with its valuation metrics suggesting a market perception significantly below traditional book value benchmarks.

财务健康

The financial performance of NEXGEL, Inc. over the trailing twelve months demonstrates a revenue stream of $11.42 million, contrasted against a net income loss of $3,000,000 and an EBITDA figure of $-2,902,000. The substantial gap between the positive revenue of $11.42 million and the negative net income of $3,000,000 reveals a cost structure where operating expenses and other charges significantly erode the bottom line, resulting in a profit margin of -26.3%. Furthermore, the operating margin stands at -43.4%, indicating that core business operations are generating losses before interest and taxes, while the gross margin of 39.5% suggests that the cost of goods sold allows for nearly 40% revenue retention before overhead costs are applied. The company reported a free cash flow of $-1,753,250, which indicates a current lack of financial flexibility to fund capital expenditures or debt obligations without external financing. On the balance sheet, the firm holds cash of $317,000 against total debt of $3.09 million, resulting in a debt-to-equity ratio of 63.14, which characterizes the capital structure as highly leveraged relative to its equity base. Liquidity is supported by a current ratio of 1.47, suggesting that current assets are 1.47 times the value of current liabilities, providing a moderate buffer for short-term obligations. Return on equity is reported at -52.7% and return on assets at -19.5%, metrics that collectively reveal that management effectiveness in generating returns on invested capital is currently negative across both equity and asset bases.

估值评估

Valuation multiples for NEXGEL, Inc. show a trailing P/E ratio and forward P/E ratio that are not available, a common characteristic for companies reporting net losses where earnings per share are negative. The absence of a positive trailing P/E and forward P/E implies that traditional earnings-based valuation models cannot be applied, forcing reliance on alternative metrics to assess value. The price-to-book ratio is recorded at 0.06, indicating that the market values the company at 6% of its book value, suggesting a significant market discount or a perception of substantial intangible value not captured on the balance sheet. Alternative valuation metrics such as the price-to-sales ratio and EV/EBITDA are also not available, as the company's negative earnings preclude the calculation of meaningful EV/EBITDA multiples. The stock price has a 52-week high of $0.04 and a 52-week low of $0.04, meaning the current trading price sits exactly at both the high and low of the year, reflecting extreme price compression with no intrayear movement. The beta value is not available, so the specific price volatility relative to the broader market cannot be quantified using standard historical data.

Growth & Income

Revenue growth year-over-year is recorded at -8.1%, while earnings growth is not applicable due to the negative earnings history. The contraction in revenue of 8.1% indicates a shrinking top line, and since earnings are already negative, the relationship between earnings growth and revenue growth is not mathematically definable in the traditional sense. As a non-dividend payer, the company does not distribute a dividend yield or a payout ratio to shareholders, as the payout ratio is not available and the firm retains cash reserves or utilizes them to service its debt. The overall growth and income profile of NEXGEL, Inc. is characterized by declining revenue and negative earnings, with no current income distribution to investors and no available data to suggest a trajectory toward profitability or revenue expansion in the immediate future.